Minority interests and associates in LBO

Hey,


I have a 3 h LBO case study coming up. Lets say we are acquiring a company with non-controlling interests on its balance sheet as well as associates (we acquire 100%). 


Question 1: Since we acquire 100%, we must take out minority shareholders and thus include minority interest in our equity-to-EV bridge. We then adjust our balance sheet to remove minority interest. Correct?

Question 2: How would you handle associates? One alternative is to assume it is sold before close and thus included in cash and cash equivalents. The other alternative would be to included it in our Uses part of the S&U as it is not included in EV (it is subtracted when going from equity to EV). We would then remove it from balance sheet. Which alternative would you go for?

Question 3: Would a "better" option be to ignore these two items completely in the case study?



 

I am always in the camp of just make it clear. 

The thing I like about including it in the sources and uses is if it was in the original balance sheet you can map to it being removed.

But you can also just footnote it, just be consistent clear, and able to communicate what you did and you will be fine. 

 

Q1: a NCI is a minority shareholder in a subsidiary, so you can buy 100% of holding and not own the NCI shares. Make sure to value the NCI separatly as book value is not an appropiate proxy of its value often.

Q2: privately owned associates are not all of a sudden sold at book value, so no. In general you acquire them with the company so you have to fund them. They require a separate valuation too. Alternatives are to be negotiated with seller. So value of associates is a use of cash, so you need a source to fund it.

Q3: no.

 
Most Helpful

Rover-S

Q1: a NCI is a minority shareholder in a subsidiary, so you can buy 100% of holding and not own the NCI shares. Make sure to value the NCI separatly as book value is not an appropiate proxy of its value often.

Q2: privately owned associates are not all of a sudden sold at book value, so no. In general you acquire them with the company so you have to fund them. They require a separate valuation too. Alternatives are to be negotiated with seller. So value of associates is a use of cash, so you need a source to fund it.

Q3: no.

Q1. I guess you are right. How to reflect this in the S&U if the minority shareholders wish to remain in the biz vs sell their stake to the PE firm as well? If they wish to remain minority holders, would you simply add it under "Uses" as a "roll-over" item similar to how a management stake is rolled-over? And if they are exiting I guess you would just include it as a Use of cash (it is included in EV)?

 

thanks. I think the second alternative is more intuitive. Given we roll-over the NCI it is treated as a source (similar to how management roll-over would be treated in the S&U)

 

Eaque blanditiis eveniet voluptatem neque beatae eos. Reprehenderit ratione sit sed est modi voluptatem. Sapiente nobis sed neque eius est quas qui. Rerum hic error fuga sequi ea id voluptas. Ipsa officiis corporis maxime occaecati. Non earum atque impedit vitae ut voluptatem optio.

Vel voluptates commodi esse ut officiis voluptatibus. Recusandae quod dignissimos et dicta qui. Quod aut dolorum sed numquam vel temporibus et.

Career Advancement Opportunities

May 2024 Private Equity

  • The Riverside Company 99.5%
  • Blackstone Group 99.0%
  • Warburg Pincus 98.4%
  • KKR (Kohlberg Kravis Roberts) 97.9%
  • Bain Capital 97.4%

Overall Employee Satisfaction

May 2024 Private Equity

  • The Riverside Company 99.5%
  • Blackstone Group 98.9%
  • KKR (Kohlberg Kravis Roberts) 98.4%
  • Ardian 97.9%
  • Bain Capital 97.4%

Professional Growth Opportunities

May 2024 Private Equity

  • The Riverside Company 99.5%
  • Bain Capital 99.0%
  • Blackstone Group 98.4%
  • Warburg Pincus 97.9%
  • Starwood Capital Group 97.4%

Total Avg Compensation

May 2024 Private Equity

  • Principal (9) $653
  • Director/MD (22) $569
  • Vice President (92) $362
  • 3rd+ Year Associate (91) $281
  • 2nd Year Associate (206) $268
  • 1st Year Associate (389) $229
  • 3rd+ Year Analyst (29) $154
  • 2nd Year Analyst (83) $134
  • 1st Year Analyst (246) $122
  • Intern/Summer Associate (32) $82
  • Intern/Summer Analyst (316) $59
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”